CompanyGraph
Nolato AB
NOLA.B · Nasdaq Stockholm · Sweden
Price data from its NOLABs listing on CBOE
nolato.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $1.73B, above the global median of $1.15B
- PositionGross margin is 17.9%, lower than 95% of its Medical Devices peers (median 61%)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.28%Above 5Y avg (2.96%)
Annual Rate
SEK 1.70Paid annual
Payout Ratio
64.1%Moderate
Last Ex-Dividend
May 7, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
16.38BSEK1.73B · vs all stocks (USD)
Trailing P/E
19.58xvs Medical Devices peers
Revenue (TTM)
9.43BSEK996.13M · vs all stocks (USD)
Profit Margin
7.60%vs Medical Devices peers
Beta
0.7380xvs all stocks
52-Week Change
-11.05%vs all stocks
Market Capitalization
16.38BSEK1.73B · vs all stocks (USD)
Enterprise Value
15.07BSEK1.59B · vs all stocks (USD)
Trailing P/E
19.58xvs Medical Devices peers
Forward P/E
17.71xvs Medical Devices peers
PEG Ratio
-1.32xvs Medical Devices peers
Price to Sales (TTM)
1.48xvs Medical Devices peers
Price to Book (MRQ)
2.46xvs Medical Devices peers
Enterprise to Revenue
1.60xvs Medical Devices peers
Enterprise to EBITDA
10.02xvs Medical Devices peers
Gross Margin
17.89%vs Medical Devices peers
Profit Margin
7.60%vs Medical Devices peers
Operating Margin
9.66%vs Medical Devices peers
Return on Assets (TTM)
6.38%vs Medical Devices peers
Return on Equity (TTM)
13.05%vs Medical Devices peers
Revenue (TTM)
9.43BSEK996.13M · vs all stocks (USD)
Revenue per Share (TTM)
34.99SEKUpdated Aug 22, 2026Quarterly Revenue Growth
2.50%vs Medical Devices peers
Gross Profit (TTM)
1.70BSEK180.10M · vs all stocks (USD)
EBITDA (TTM)
979.00MSEK103.47M · vs all stocks (USD)
Net Income (TTM)
716.00MSEK75.67M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-20.30%vs Medical Devices peers
Operating Cash Flow (TTM)
1.12BSEK118.69M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
166.50MSEK17.60M · vs all stocks (USD)
Trailing Annual Dividend Rate
1.70SEKUpdated Aug 22, 2026Trailing Annual Dividend Yield
3.28%vs all stocks
5-Year Average Dividend Yield
2.96%vs all stocks
Payout Ratio
64.15%vs Medical Devices peers
Revenue
9.46BSEKFY2025 · Dec 31, 2025Cost of Goods Sold
7.73BSEKFY2025 · Dec 31, 2025Gross Profit
1.73BSEKFY2025 · Dec 31, 2025Operating Income
1.02BSEK108.23M · vs all stocks (USD)
Pre-tax Income
983.00MSEKFY2025 · Dec 31, 2025Income Tax Expense
206.00MSEKFY2025 · Dec 31, 2025Net Income
777.00MSEKFY2025 · Dec 31, 2025EBIT
1.02BSEKFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.02BSEKFY2025 · Dec 31, 2025Selling, General & Administrative
754.00MSEKFY2025 · Dec 31, 2025Other Operating Expenses
-48.00MSEKFY2025 · Dec 31, 2025EPS (Basic)
2.88SEKFY2025 · Dec 31, 2025EPS (Diluted)
2.88SEKFY2025 · Dec 31, 2025Basic Shares Outstanding
269.38MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
269.38MSharesFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00SEKFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
482.00MSEKFY2025 · Dec 31, 2025Shares Outstanding
269.38MSharesUpdated Aug 22, 2026Float Shares
149.53MSharesUpdated Aug 22, 2026% Held by Insiders
20.79%vs all stocks
% Held by Institutions
57.43%vs all stocks
Total Cash (MRQ)
482.00MSEK50.94M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.79SEKUpdated Aug 22, 2026Total Debt (MRQ)
1.76BSEK186.23M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3105xvs Medical Devices peers
Current Ratio (MRQ)
1.56xvs Medical Devices peers
Book Value per Share (MRQ)
21.07SEKUpdated Aug 22, 2026Total Assets
9.28BSEK981.01M · vs all stocks (USD)
Total Current Assets
3.72BSEKFY2025 · Dec 31, 2025Total Liabilities
3.75BSEKFY2025 · Dec 31, 2025Total Non-current Assets
5.56BSEKFY2025 · Dec 31, 2025Total Non-current Liabilities
1.59BSEKFY2025 · Dec 31, 2025Total Current Liabilities
2.16BSEKFY2025 · Dec 31, 2025Cash
482.00MSEKFY2025 · Dec 31, 2025Cash & Cash Equivalents
482.00MSEKFY2025 · Dec 31, 2025Accounts Receivable
1.60BSEKFY2025 · Dec 31, 2025Inventory
1.09BSEKFY2025 · Dec 31, 2025Other Current Liabilities
2.15BSEKFY2025 · Dec 31, 2025Other Non-current Liabilities
1.32BSEKFY2025 · Dec 31, 2025Total Shareholders' Equity
5.53BSEK584.68M · vs all stocks (USD)
52-Week Low
44.80SEKUpdated Aug 22, 202652-Week High
64.65SEKUpdated Aug 22, 202652-Week Change
-11.05%vs all stocks
Beta
0.7380xvs all stocks
50-Day MA
49.16SEKUpdated Aug 22, 2026200-Day MA
52.89SEKUpdated Aug 22, 2026Avg 10-Day Volume
252.74KSharesUpdated Aug 22, 2026Avg 30-Day Volume
196.69KSharesUpdated Aug 22, 2026Diluted EPS (TTM)
2.65SEKUpdated Aug 22, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
Where is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 17.9%, lower than 95% of its Medical Devices peers (median 61%)Significant
Gross margin: 0.18Industry median: 0.61Industry P5: 0.28Peers compared: 102
Financial Health
Altman Z-Score 4.21: safe zoneNotable
Altman Z-Score: 4.21
High earnings qualityNotable
Earnings Quality Score: 0.99
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $1.73B, above the global median of $1.15BNotable
Market cap (USD): 1,731,004,185.98Global Median: 1,146,734,693.424
Revenue is $996.13M, above the global median of $520.53MNotable
Revenue (USD): 996,128,297.349Global Median: 520,528,949.311
Levered free cash flow is $17.6M, above the global median of $16.24MNotable
Levered free cash flow (USD): 17,597,385Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Butterfly Network Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Alivus Life Sciences Limited
Tier 1ProductionApproval-Gated PipelineRuleFlow
Tibet Cheezheng Tibetan Medicine Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Inventisbio Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Harrow Inc.
Tier 1ProductionApproval-Gated PipelineRule
Pharmablock Sciences Nanjing Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
MapLight Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
4DMedical Limited
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Taysha Gene Therapies Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Shanghai Shyndec Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Avery Dennison Corporation
2 interpretationsIndustry-Benchmarked Return on Capital ElevatedReceivables Heavy and Growing
Krishana Phoschem Ltd.
2 interpretationsIndustry-Benchmarked Return on Capital ElevatedReceivables Heavy and Growing
Celestica Inc.
2 interpretationsIndustry-Benchmarked Return on Capital ElevatedReceivables Heavy and Growing